标的公司与上市公司同属于功率半导体企业，深耕功率器件多年，能够提供全系列的电路保护方案。双 方在业务上具有较高的协同性，双方优势产品线可实现深度互补，共同构建覆盖更广泛应用场景、技术 规格更齐全的综合功率半导体解决方案。这将显著增强满足客户多元化、高性能需求的能力。同时，通 过研发资源整合与核心技术共享，双方有望在器件设计、工艺优化及封装技术等方面产生协同效应，加 速技术创新迭代，共同提升在功率半导体领域的技术壁垒与核心竞争力。 通过本次交易，标的公司的核心产品能够进一步完善上市公司在功率半导体的布局，丰富产品体系。标 的公司已在汽车电子、工业控制、消费电子、安防、光伏储能、网络通信等多个下游应用领域建立了稳 固的客户基础和销售渠道，上市公司当前优势集中于以智能手机为代表的消费电子领域，本次交易将形 成较为明显的市场协同效应。通过本次交易，上市公司可以借助标的公司的优质客户资源进入到汽车电 子、工业控制、安防、光伏储能、网络通信等下游应用领域，标的公司也可以借助上市公司的市场渠道 及客户资源，巩固和强化其在工业等领域的布局，同时扩大消费电子领域的市场占有率。 芯导科技(688230.SH)发布公告，公司拟向盛 ...

Group 1 - The A-share market is experiencing a surge in mergers and acquisitions (M&A), with 113 disclosed M&A events by August 5, more than double the number from the same period last year, focusing on strategic emerging industries such as electronic components, new energy, and biotechnology [1] - Large-scale M&A cases are frequent this year, with some transactions exceeding 10 billion yuan, primarily targeting companies with core technologies and high growth potential [1] - The types of transactions are increasingly characterized by horizontal integration to enhance market share and vertical extension to improve supply chains, reflecting a trend towards value-driven and industry chain collaboration [1] Group 2 - The current period of technological innovation is highly active, with emerging and future industries showing strong development momentum, making M&A a key pathway for companies to achieve innovation and transformation [2] - Lionhead Technology Co., Ltd. plans to acquire 100% of the shares of Hangzhou Liper Technology Co., Ltd. through a combination of stock issuance and cash payment, aiming to enter the machine vision field and create a second growth curve [2] Group 3 - Traditional companies lacking high-tech businesses view M&A as a crucial method for rapid industrial transformation [3] - Nanjing Chemical Fiber Co., Ltd. is seeking to acquire 100% of Nanjing Process Equipment Manufacturing Co., Ltd. through asset swaps and cash payments, shifting its main business focus to the research, production, and sales of rolling functional components [3] Group 4 - A-share M&A activities are evolving from single enterprise mergers to comprehensive collaboration across industry chains, innovation chains, and supply chains, focusing on upstream and downstream integration [4] - Shanghai Xindao Electronics Technology Co., Ltd. plans to acquire 100% of Shanghai Shunlei Technology Co., Ltd., aiming for business synergy and enhanced competitiveness in the power semiconductor field [4] - Beijing Lideman Biochemical Co., Ltd. intends to acquire up to 70% of Beijing Xiansheng Xiangrui Biological Products Co., Ltd., expanding its IVD business to include tuberculosis diagnosis and treatment [4] Group 5 - The Chinese biopharmaceutical sector is witnessing a recovery in investment and financing, with government policies supporting industry consolidation [5] - Future M&A activities are expected to play a key role in optimizing resource allocation, enhancing technological research and business expansion, and driving innovation in emerging industries [5]